These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


404 related items for PubMed ID: 24577126

  • 1. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK, An H, Shin KH, Shin D, Lee SH, Kim JH, Cho SH, Kang HR, Jang IJ, Yu KS, Lim KS.
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [Abstract] [Full Text] [Related]

  • 2. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A, Mergenhagen KA, Mattappallil A.
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [Abstract] [Full Text] [Related]

  • 3. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH, Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group.
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [Abstract] [Full Text] [Related]

  • 4. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
    Masuda N, Maiguma T, Komoto A, Haruki Y, Sugiyama T, Kondo S, Teshima D.
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
    [Abstract] [Full Text] [Related]

  • 5. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL, Shaffer CL, Beck GL, Simonsen KA.
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED, Hanson M, Sankaranarayanan J, Stoner JA, Florescu MC, Rupp ME.
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [Abstract] [Full Text] [Related]

  • 9. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ, Shankar V.
    Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH.
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
    Dong MH, Wang JW, Wu Y, Chen BY, Yu M, Wen AD.
    Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.